标题
CICinactivating mutations identify aggressive subset of 1p19q codeleted gliomas
作者
关键词
-
出版物
ANNALS OF NEUROLOGY
Volume 78, Issue 3, Pages 355-374
出版商
Wiley
发表日期
2015-05-28
DOI
10.1002/ana.24443
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas
- (2015) Adriana Olar et al. ACTA NEUROPATHOLOGICA
- Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas
- (2015) Yuchen Jiao et al. Oncotarget
- Mutations in CIC and IDH1 cooperatively regulate 2-hydroxyglutarate levels and cell clonogenicity
- (2015) Suganthi Chittaranjan et al. Oncotarget
- Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present
- (2014) Mathew C Casimiro et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Imaging growth and isocitrate dehydrogenase 1 mutation are independent predictors for diffuse low-grade gliomas
- (2014) C. Goze et al. NEURO-ONCOLOGY
- SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information
- (2014) Marco Biasini et al. NUCLEIC ACIDS RESEARCH
- Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma
- (2013) B. E. Johnson et al. SCIENCE
- Candidate Pathways for Promoting Differentiation or Quiescence of Oligodendrocyte Progenitor-like Cells in Glioma
- (2012) J. D. Dougherty et al. CANCER RESEARCH
- The renal v-ATPase a4 subunit is expressed in specific subtypes of human gliomas
- (2012) Vincent Gleize et al. GLIA
- Review and update ofSPRED1mutations causing legius syndrome
- (2012) Hilde Brems et al. HUMAN MUTATION
- The Capicua repressor - a general sensor of RTK signaling in development and disease
- (2012) G. Jimenez et al. JOURNAL OF CELL SCIENCE
- Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951
- (2012) Lale Erdem-Eraslan et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
- (2012) Gregory Cairncross et al. JOURNAL OF CLINICAL ONCOLOGY
- Rai is a New Regulator of Neural Progenitor Migration and Glioblastoma Invasion
- (2012) Barbara Ortensi et al. STEM CELLS
- Asymmetry-Defective Oligodendrocyte Progenitors Are Glioma Precursors
- (2011) Sista Sugiarto et al. CANCER CELL
- ATXN1 Protein Family and CIC Regulate Extracellular Matrix Remodeling and Lung Alveolarization
- (2011) Yoontae Lee et al. DEVELOPMENTAL CELL
- Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers
- (2011) Stephen Yip et al. JOURNAL OF PATHOLOGY
- Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma
- (2011) C. Bettegowda et al. SCIENCE
- Exercise and Genetic Rescue of SCA1 via the Transcriptional Repressor Capicua
- (2011) J. D. Fryer et al. SCIENCE
- ERK/p90RSK/14-3-3 signalling has an impact on expression of PEA3 Ets transcription factors via the transcriptional repressor capicúa
- (2010) Kumara Dissanayake et al. BIOCHEMICAL JOURNAL
- Non-Stem Cell Origin for Oligodendroglioma
- (2010) Anders I. Persson et al. CANCER CELL
- All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2
- (2010) M. Labussiere et al. NEUROLOGY
- Partial Loss of Ataxin-1 Function Contributes to Transcriptional Dysregulation in Spinocerebellar Ataxia Type 1 Pathogenesis
- (2010) Juan Crespo-Barreto et al. PLoS Genetics
- Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
- (2009) Marc Sanson et al. JOURNAL OF CLINICAL ONCOLOGY
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dual-specificity MAP kinase phosphatases (MKPs) and cancer
- (2008) Stephen M. Keyse CANCER AND METASTASIS REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started